(Q73393616)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746909%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746909%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Correlation of serum anti‐DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis (English)

1 reference

2 January 2024

1 reference

2 January 2024

1 reference

2 January 2024

author name string

Noreen Fertig

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746909%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Paul Q. Hu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746909

2 January 2024

Thomas A. Medsger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746909

2 January 2024

Timothy M. Wright

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746909

2 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12746909

2 January 2024

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746909%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.10977

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.10977

2 January 2024

1 reference

2 January 2024

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746909%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746909%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746909%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1363-1373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746909%20AND%20SRC:MED&resulttype=core&format=json

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

3 November 2019

cites work

3

1 reference

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients

2 January 2024

4

1 reference

The clinical significance of T-cell superantigens

2 January 2024

5

1 reference

Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.

2 January 2024

6

1 reference

High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients

2 January 2024

7

1 reference

HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients

2 January 2024

9

1 reference

Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides

2 January 2024

10

1 reference

Severe systemic sclerosis with anti-topoisomerase I Antibodies is associated with an HLA-DRw11 allele

2 January 2024

11

1 reference

The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies

2 January 2024

12

1 reference

Longitudinal Study of Anticentromere and Antitopoisomerase-I Isotypes

2 January 2024

13

1 reference

A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera

2 January 2024

14

1 reference

A long-term longitudinal isotypic study of anti-topoisomerase I autoantibodies

2 January 2024

15

1 reference

Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis

2 January 2024

17

1 reference

Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis.

2 January 2024

18

1 reference

A disease severity scale for systemic sclerosis: development and testing

2 January 2024

20

1 reference

European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.

2 January 2024

22

1 reference

Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis

2 January 2024

23

1 reference

Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis

2 January 2024

24

1 reference

Biochemical and biophysical analyses of recombinant forms of human topoisomerase I

2 January 2024

25

1 reference

The domain organization of human topoisomerase I

2 January 2024

26

1 reference

Overexpression of human DNA topoisomerase I in insect cells using a baculovirus vector

2 January 2024

27

1 reference

Molecular basis of IgG subclass deficiency

2 January 2024

28

1 reference

High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial

2 January 2024

29

1 reference

Measurement of patient outcome in arthritis

2 January 2024

30

1 reference

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

2 January 2024

31

1 reference

Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis

2 January 2024

32

1 reference

The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial

2 January 2024

33

1 reference

Assessment of damage and activity in systemic sclerosis

2 January 2024

34

1 reference

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

2 January 2024

35

1 reference

Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus

2 January 2024

36

1 reference

The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity

2 January 2024

37

1 reference

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

2 January 2024

38

1 reference

Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationships with clinical manifestations and disease activity in an Italian series

2 January 2024

40

1 reference

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

2 January 2024

41

1 reference

Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity

2 January 2024

42

1 reference

IgG1 is the dominant subclass of antibody against glutamic acid decarboxylase among type 1 diabetes in Japanese

2 January 2024

43

1 reference

Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus

2 January 2024

44

1 reference

Analysis of IgG subclasses of human antitopoisomerase I autoantibodies suggests chronic B cell stimulation

2 January 2024

45

1 reference

2 January 2024

Identifiers

DOI

10.1002/ART.10977

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12746909%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference